Simon Baker
Stock Analyst at Redburn Atlantic
(0.87)
# 2,844
Out of 4,667 analysts
8
Total ratings
25%
Success rate
1.99%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $2.80 | +364.29% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $102.14 | +66.44% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $42.09 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $115.93 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $78.04 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $45.70 | -47.48% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $2.80
Upside: +364.29%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $102.14
Upside: +66.44%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $42.09
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $115.93
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $78.04
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $45.70
Upside: -47.48%